Larvol Delta - PLX038-for-the-Treatment-of-Patients-With-Platinumresistant-Ovarian-Primary-Peritoneal-and-Fallopian-Tube-Cancer

firtecan pegol (PEG-SN38) - Belrose

PLX038 - ProLynx

http://clinicaltrials.gov/ct2/show/NCT05465941

Sep 15, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next